Nobutoshi Ando

6.7k citations
96 papers · 5.2k indexed · 2 hit papers · h-index 31

Impact in

    • Gastric Cancer Management and Outcomes
    • Lung Cancer Diagnosis and Treatment
    • Metastasis and carcinoma case studies
    • Lung Cancer Treatments and Mutations
  • Surgery top 0.5%
    • Esophageal Cancer Research and Treatment
    • Esophageal and GI Pathology

Papers in

    • Esophageal Cancer Research and Treatment 48
    • Esophageal and GI Pathology 28
    • Tissue Engineering and Regenerative Medicine 5
    • Gastric Cancer Management and Outcomes 31
    • Lung Cancer Treatments and Mutations 9
    • Lung Cancer Diagnosis and Treatment 6

Nobutoshi Ando

92 papers receiving 5.0k citations

Hit Papers

A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) 2011 · 1.1k citations
1.1k20032026201020182505007501000

Peers

Nobutoshi Ando
Comparison fields: 5 of 109
  • Pulmonary and Respiratory Medicine 3.4k
  • Surgery 3.8k
  • Gastroenterology 246
  • Oncology 1.1k
  • Otorhinolaryngology 105
Replace Kensuke Esato with:
Kensuke Esato Japan
Petra Rümmele Germany
Justin Cates United States
Michael Hofmann Germany
Yoshiaki Kuriu Japan
Sunjay Kaushal United States
Shigeyuki Tamura Japan
Wataru Takiyama Japan
J. Veit Germany
Koji Okabayashi Japan
Nobutoshi Ando relative to Kensuke Esato Japan Kensuke Esato's profile →
Citations per field
00.5×10×14.5×
Kensuke Esato · 1×
Citations per year

Countries citing papers authored by Nobutoshi Ando

Since Specialization
Citations

This map shows the geographic impact of Nobutoshi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutoshi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutoshi Ando more than expected).

Fields of papers citing papers by Nobutoshi Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobutoshi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutoshi Ando. The network helps show where Nobutoshi Ando may publish in the future.

Co-authors

The 25 scholars most cited alongside Nobutoshi Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nobutoshi Ando Line = papers co-authored together Nobutoshi Ando links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
Hit paper breakdown →
20111062
2
Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204
Hit paper breakdown →
2003546
3 2000463
4 2013229
5 2000225
6 1997215
7 2016165
8 1989157
9 2016143
10 1987131
11 2015122
12
Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
1991114
13 201294
14 200994
15 200978
16 199969
17 199867
18 199866
19 198862
20 198855

About Nobutoshi Ando

Nobutoshi Ando is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 96 papers that have together received 5.2k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (48 papers), Gastric Cancer Management and Outcomes (31 papers), Esophageal and GI Pathology (28 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (6 papers), Tissue Engineering and Regenerative Medicine (5 papers), HER2/EGFR in Cancer Research (5 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.4k citations), Surgery (3.8k citations), Gastroenterology (246 citations), Oncology (1.1k citations) and Otorhinolaryngology (105 citations). Nobutoshi Ando has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Soji Ozawa, Yuko Kitagawa, Masaki Kitajima, Masakazu Ueda, Haruhiko Fukuda, Masayuki Shinoda, Hiroyasu Igaki, Osahiko Abe, Nobuyoshi Shimizu and Norio Aoyama. Their work appears in journals such as International Journal of Cancer, Cancer, Japanese Journal of Clinical Oncology, Esophagus and ASAIO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact